Does DARBEPOETIN ALFA Cause Hyperphosphataemia? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Hyperphosphataemia have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.4% of all adverse event reports for DARBEPOETIN ALFA.
116
Reports of Hyperphosphataemia with DARBEPOETIN ALFA
0.4%
of all DARBEPOETIN ALFA reports
110
Deaths
105
Hospitalizations
How Dangerous Is Hyperphosphataemia From DARBEPOETIN ALFA?
Of the 116 reports, 110 (94.8%) resulted in death, 105 (90.5%) required hospitalization, and 96 (82.8%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which DARBEPOETIN ALFA Alternatives Have Lower Hyperphosphataemia Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE